Unplanned adaptations before breaking the blind

Occasionally, things go so wrong in a clinical trial that a change must be made. For example, the originally planned primary outcome may be measured completely unreliably. Is there any recourse? One may still be able to salvage the trial using a permutation test if a change is made before breaking the treatment blind. The solution is not a panacea; we discuss the limitations and legitimate grounds for criticism. Still, when it is needed, the procedure is preferable to rigid adherence to a design that makes no sense. Published 2012. This article is a US Government work and is in the public domain in the USA.

[1]  H. Schäfer,et al.  A general statistical principle for changing a design any time during the course of a trial , 2004, Statistics in medicine.

[2]  S. Kropf,et al.  Multiple Tests for Different Sets of Variables Using a Data‐Driven Ordering of Hypotheses, with an Application to Gene Expression Data , 2002 .

[3]  D Edwards,et al.  On model prespecification in confirmatory randomized studies. , 1999, Statistics in medicine.

[4]  A. Gould.  Planning and revising the sample size for a trial. , 1995, Statistics in Medicine.

[5]  Jurgen Lauter,et al.  Exact t and F Tests for Analyzing Studies with Multiple Endpoints , 1996 .

[6]  Russell S. Kirby,et al.  Designing Clinical Research , 2014 .

[7]  A. Gould,et al.  Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance , 1992 .

[8]  J. Hsia,et al.  Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. , 2002, JAMA.

[9]  Henry F. Diaz,et al.  ENSO variability, teleconnections and climate changeThis article is a US Government work and is in the public domain in the USA. , 2001 .

[10]  G. Hommel,et al.  Tests for Differentiation in Gene Expression Using a Data‐Driven Order or Weights for Hypotheses , 2004, Biometrical journal. Biometrische Zeitschrift.

[11]  Steven Piantadosi,et al.  Patients at high risk of death after lung-volume-reduction surgery. , 2001, The New England journal of medicine.

[12]  Biao Xing,et al.  A method to estimate the variance of an endpoint from an on-going blinded trial. , 2005, Statistics in medicine.

[13]  Meinhard Kieser,et al.  Simple procedures for blinded sample size adjustment that do not affect the type I error rate , 2003, Statistics in medicine.

[14]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[15]  U. Prakash,et al.  Patients at high risk of death after lung-volume–reduction surgery. , 2002 .

[16]  Steven Piantadosi,et al.  A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.

[17]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[18]  Jurg. Hiisler.  On the two-sample adaptive distribution-free test , 1987 .

[19]  W. Brannath,et al.  Probabilistic Foundation of Confirmatory Adaptive Designs , 2012 .

[20]  P. Westfall,et al.  Weighted FWE-controlling methods in high-dimensional situations , 2004 .